Imexpharm Pharmaceutical JSC (IMP) has reported a strong profit rebound in the second quarter of 2025, driven mainly by a ...

HSBC (NYSE:HSBC) reopened its search for a new chair after its initial shortlist failed to produce a suitable successor for Sir Mark Tucker, despite considering more than 100 potential candidates, the ...